Australia vs Mongolia: Proportion of isolates with decreased susceptibility or resistance
Australia
0.01
in 2020
Mongolia
0.7752
in 2018
Australia rank
12th
Mongolia rank
9th
Proportion of isolates with decreased susceptibility or resistance over time
- Australia
- Mongolia
How they compare
Mongolia currently reports 0.7752 against 0.01 in Australia, a difference of 0.7652.
That makes Mongolia's figure about 77.5 times Australia's.
The two have swapped places 2 times across 6 shared years of data; in 2009 it was Mongolia ahead.
Australia ranks 12th and Mongolia ranks 9th of 52 countries.
Mongolia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Australia | Mongolia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0317 | 19.13 | 19.1 | Mongolia |
| 2010s | 0.502 | 11.33 | 10.83 | Mongolia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with decreased susceptibility or resistance, Australia or Mongolia?
- Mongolia, at 0.7752 against 0.01 in Australia as of 2018.
- What is the difference in proportion of isolates with decreased susceptibility or resistance between Australia and Mongolia?
- 0.7652, with Mongolia ahead.
- How many years of comparable data are there for Australia and Mongolia?
- 6 years are reported by both, from 2009 to 2018.
- How do Australia and Mongolia rank globally for proportion of isolates with decreased susceptibility or resistance?
- Australia ranks 12th and Mongolia ranks 9th of 52 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with decreased susceptibility or resistance (DS/R) to ceftriaxone reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.